Chevallier P, Thiebaut A, François S, Chantepie S, Rubio M-T, Labussiere-Wallet H, Brissot E, Maillard N, Huynh A, Coiteux V, Jullien M, Garnier A, Le Bourgeois A, Peterlin P, Guillaume T. A phase II study of ponatinib for prevention of relapse after allogeneic transplantation in FLT3 internal tandem duplication mutation-positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial. Haematologica 2025;110(10):2525-2529; https://doi.org/10.3324/haematol.2025.287681.